Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
Clinical trial NCT06932263 · RECRUITING
Trial details
- NCT number
- NCT06932263
- Sponsor
- AstraZeneca
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-26
- Primary completion
- 2027-06-07
- Enrollment
- 540
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.